SiMSen Diagnostics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

SiMSen Diagnostics General Information

Description

Developer of healthcare technology designed to maximize the potential of ultrasensitive sequencing to improve healthcare. The company's technology combines SiMSen seq with two-tailed PCR with DNA analysis specific for cancer, enabling the medical industry to customize pharma therapy for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pepparedsleden 1
  • C/o AstraZeneca BioVentureHub
  • 431 83 Mölndal
  • Sweden
+46 076-022
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Pepparedsleden 1
  • C/o AstraZeneca BioVentureHub
  • 431 83 Mölndal
  • Sweden
+46 076-022

SiMSen Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SiMSen Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
2. Early Stage VC 05-May-2023 Completed Generating Revenue
1. Early Stage VC 01-Jan-2021 $272K $272K Completed Generating Revenue
To view SiMSen Diagnostics’s complete valuation and funding history, request access »

SiMSen Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view SiMSen Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SiMSen Diagnostics Patents

SiMSen Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4573214-A1 Nucleic acid amplification Active 15-Aug-2022
EP-4573214-B1 Nucleic acid amplification Active 15-Aug-2022
EP-4573214-C0 Nucleic acid amplification Active 15-Aug-2022
US-20250361550-A1 Nucleic acid amplification Pending 15-Aug-2022
WO-2024039272-A1 Nucleic acid amplification Inactive 15-Aug-2022 C12Q1/6853
To view SiMSen Diagnostics’s complete patent history, request access »

SiMSen Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SiMSen Diagnostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
GOBIA Enterprises Venture Capital Minority
GoKap Invest Venture Capital Minority
JFB Invest Venture Capital Minority
Nordic Ignite Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

SiMSen Diagnostics FAQs

  • When was SiMSen Diagnostics founded?

    SiMSen Diagnostics was founded in 2020.

  • Where is SiMSen Diagnostics headquartered?

    SiMSen Diagnostics is headquartered in Mölndal, Sweden.

  • What is the size of SiMSen Diagnostics?

    SiMSen Diagnostics has 7 total employees.

  • What industry is SiMSen Diagnostics in?

    SiMSen Diagnostics’s primary industry is Diagnostic Equipment.

  • Is SiMSen Diagnostics a private or public company?

    SiMSen Diagnostics is a Private company.

  • What is SiMSen Diagnostics’s current revenue?

    The current revenue for SiMSen Diagnostics is .

  • How much funding has SiMSen Diagnostics raised over time?

    SiMSen Diagnostics has raised $1.22M.

  • Who are SiMSen Diagnostics’s investors?

    Nordic Mentor Network For Entrepreneurship, GOBIA Enterprises, GoKap Invest, JFB Invest, and Nordic Ignite are 5 of 6 investors who have invested in SiMSen Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process